102 related articles for article (PubMed ID: 21068651)
1. Falsely elevated whole blood cyclosporine concentrations measured by an immunoassay with automated pretreatment.
Bartoli A; Molinaro M; Visai L
Ther Drug Monit; 2010 Dec; 32(6):791-2. PubMed ID: 21068651
[No Abstract] [Full Text] [Related]
2. Apparent elevation of cyclosporine whole blood concentrations in a renal allograft recipient.
de Jonge H; Geerts I; Declercq P; de Loor H; Claes K; Desmet K; Kuypers DR
Ther Drug Monit; 2010 Oct; 32(5):529-31. PubMed ID: 20625351
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients.
Huet E; Morand K; Blanchet B; Astier A; Hulin A
Transplant Proc; 2004 Jun; 36(5):1317-20. PubMed ID: 15251322
[TBL] [Abstract][Full Text] [Related]
4. Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand dimension.
Barau C; Frangie C; Goujard C; Tribut O; Parant F; Taburet AM; Durrbach A; Furlan V
Ther Drug Monit; 2009 Apr; 31(2):267-8. PubMed ID: 19214146
[TBL] [Abstract][Full Text] [Related]
5. False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review.
Taguchi K; Ohmura T; Ohya Y; Horio M; Furukawa K; Jono H; Inomata Y; Saito H
Exp Clin Transplant; 2014 Oct; 12(5):474-8. PubMed ID: 24206050
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
7. [Cyclosporine].
Yuhki Y; Tadano K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():461-4. PubMed ID: 15658363
[No Abstract] [Full Text] [Related]
8. Importance of CsA drug monitoring in SCT recipients to minimize GVHD and maximize graft vs. leukemia.
Barkholt L
Pediatr Transplant; 2009 Jun; 13(4):400-3. PubMed ID: 18992059
[No Abstract] [Full Text] [Related]
9. Clinically unexpected cyclosporine levels using the ACMIA method on the RXL dimension analyser.
Morelle J; Wallemacq P; Van Caeneghem O; Goffin E
Nephrol Dial Transplant; 2011 Apr; 26(4):1428-31. PubMed ID: 21335442
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of the new ADVIA Centaur system cyclosporine assay (single-step extraction).
Soldin SJ; Hardy RW; Wians FH; Balko JA; Mendu DR; Chaffin CH; Streit F; Barbarakis M; Martel J; Canfield W; Levy HR; Oellerich M
Clin Chim Acta; 2010 Jun; 411(11-12):806-11. PubMed ID: 20188087
[TBL] [Abstract][Full Text] [Related]
11. The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation.
Stephens E; Bolderson I; Clark B; Kinsey S; Gooi HC; Cook G
Ann Clin Biochem; 2006 Sep; 43(Pt 5):382-8. PubMed ID: 17022881
[TBL] [Abstract][Full Text] [Related]
12. [The clinical usefulness of cyclosporine therapeutic monitoring].
Di Fede G; Iacò V; Pepe S; Salerno L
Clin Ter; 1999; 150(5):339-42. PubMed ID: 10687263
[TBL] [Abstract][Full Text] [Related]
13. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
14. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclophosphamide on serum cyclosporine levels at the conditioning of hematopoietic stem cell transplantation.
Nagamura F; Takahashi T; Takeuchi M; Iseki T; Ooi J; Tomonari A; Uchimaru K; Takahashi S; Tojo A; Tani K; Asano S
Bone Marrow Transplant; 2003 Dec; 32(11):1051-8. PubMed ID: 14625575
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic monitoring by blood concentrations with the focus on cyclosporin A].
Jensen SA; Dalhoff KP
Ugeskr Laeger; 2001 Apr; 163(14):2009-12. PubMed ID: 11307363
[TBL] [Abstract][Full Text] [Related]
17. [A new strategy for monitoring levels of cyclosporin A in the blood of patients after kidney transplantation].
Halacová M; Jedlicková B; Průsa R
Ceska Slov Farm; 2003 Nov; 52(6):267-71. PubMed ID: 14661365
[TBL] [Abstract][Full Text] [Related]
18. [Cyclosporine].
Yuhki Y; Tadano K; Takahashi Y
Nihon Rinsho; 1999 Sep; 57 Suppl():428-31. PubMed ID: 10543145
[No Abstract] [Full Text] [Related]
19. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
[TBL] [Abstract][Full Text] [Related]
20. Specimen dilution for C2 monitoring with the Abbott TDxFLx cyclosporine monoclonal whole blood assay.
Juenke JM; Brown PI; Urry FM; McMillin GA
Clin Chem; 2004 Aug; 50(8):1430-3. PubMed ID: 15277354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
